Suppr超能文献

抗心律失常药物:风险与收益。

Antiarrhythmic Drugs: Risks and Benefits.

机构信息

Department of Cardiology, Virginia Commonwealth University Health System, PO Box 980053, Richmond, VA 23235, USA.

Department of Electrophysiology, Virginia Commonwealth University Health System, PO Box 980053, Richmond, VA 23235, USA.

出版信息

Med Clin North Am. 2019 Sep;103(5):821-834. doi: 10.1016/j.mcna.2019.05.004. Epub 2019 Jul 6.

Abstract

The narrow therapeutic window of antiarrhythmic drugs makes their use clinically challenging. A solid understanding of the mechanisms of arrhythmias and how antiarrhythmics affect these mechanisms is only a preliminary step in their appropriate selection. Clinical factors, side-effect profiles, and proarrhythmic risks are more important than the cellular mechanisms of actions in drug selection and monitoring. This article provides a simplified approach to understanding cellular mechanisms and provides a practical approach to the selection and use of this important class of medications.

摘要

抗心律失常药物的治疗窗狭窄,使其在临床上的应用具有挑战性。深入了解心律失常的机制以及抗心律失常药物如何影响这些机制,只是正确选择药物的初步步骤。在药物选择和监测中,临床因素、副作用特征和致心律失常风险比药物作用的细胞机制更为重要。本文提供了一种简化理解细胞机制的方法,并提供了一种实用的方法来选择和使用这一重要类别的药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验